Dr. Milton Werner is the President and CEO of Inhibikase Therapeutics, a company developing novel protein kinase inhibitor therapeutics to treat neurodegenerative disease and viral infection inside and outside of the brain.
— Sachs Associates (@SachsAssociates) March 30, 2021
e-Meet Dr. Milton Werner at #Sachs_NIF pic.twitter.com/TY31qyMB47